首页 | 本学科首页   官方微博 | 高级检索  
     

思连康治疗肝硬化腹泻的疗效观察
引用本文:薛鸿鹏,祝喜萍,陆以霞,孙媛媛,郭文敏. 思连康治疗肝硬化腹泻的疗效观察[J]. 中国医学装备, 2009, 6(6): 39-40
作者姓名:薛鸿鹏  祝喜萍  陆以霞  孙媛媛  郭文敏
作者单位:黑龙江省医院附属消化病医院,黑龙江,哈尔滨,150001
摘    要:目的:观察思连康治疗肝硬化腹泻的疗效。方法:83例病人随机分成两组,治疗组41例,口服思连康(每次两粒,每日三次)2周;对照组42例,口服思密达(每次一袋,每日三次)2周。结果:治疗组有效率为87.80%,对照组有效率为64.28%,两组间比较有显著性差异(P〈0.01)。结论:思连康是治疗肝硬化腹泻的有效药物。

关 键 词:思连康  肝硬化  腹泻

Observation of curative effect of silico on liver cirrhosis-related diarrhea
Xue Hongpeng,Zhu Xiping,Lu Yixia,Sun Yuanyuan,Guo Wenmin. Observation of curative effect of silico on liver cirrhosis-related diarrhea[J]. China Medical Equipment, 2009, 6(6): 39-40
Authors:Xue Hongpeng  Zhu Xiping  Lu Yixia  Sun Yuanyuan  Guo Wenmin
Affiliation:(The Affiiiated Gastroenterology Hospital of Heilongjiang Provincial Hospital, Harbin 150001, China.)
Abstract:Objective: To observe the curative effect of silico on liver cirrhosis - related diarrhea. Methods: A total of 85 patients were divided into two groups randomly. Forty-one 41 cases in the experimental group took silico orally (two pills toties quoties, tid) for two weeks and 42 in the control group took Smecta (dioctahedral smectite) orally (one pouch toties quoties, tid) for two weeks. Results: The effective rates were 87.80% and 64.28% in the experimental group and the control group, respectively. There was significant difference between the 2 groups (p〈0.01). Conclusion: Silico is effective for treatment of liver cirrhosis- related diarrhea.
Keywords:Silico  Liver cirrhosis  Diarrhea
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号